PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsimmunization
MeSH D007114 - immunization
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007167:Immunotherapy
0 Companies
0 Drugs
Success rate
D007114: 
Immunization
13 Companies
1 Drug
$
Success rate
D007116:Passive immunization
2 Companies
1 Drug
$
Success rate
D007117:Secondary immunization
0 Companies
0 Drugs
Success rate
D016233:Active immunotherapy
0 Companies
0 Drugs
Success rate
D014611:Vaccination
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Merck & CoHepatitis b virus hbsag surface protein antigen HBVaxPro  2001-04-27   
Evans VaccinesHepatitis b virus hbsag surface protein antigen Hepacare  2000-08-04   
1
2
>
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Sanofi
Recombivax,
Fendrix,
Fluzone,
Pneumovax,
Flumist,
Flucelvax,
Prevenar
Merck & Co
Hepatitis b virus hbsag surface protein antigen
Pfizer
Pneumovax,
Prevenar
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use